Skip to main content
Contact us
Company

The minds behind Tempo.

Tempo Therapeutics is a privately held, clinical-stage regenerative medicine company in San Diego, developing synthetic biomaterials designed to enable the body to regenerate healthy tissue.

Leadership
Eric Richman, MBA

Eric Richman, MBA

Chief Executive Officer

Westbrook Weaver, PhD

Westbrook Weaver, PhD

Founder & Chief Technology Officer

Donald Griffin, PhD

Donald Griffin, PhD

Founder & Chief Scientific Officer

Stephanie Deshayes, PhD

Stephanie Deshayes, PhD

Vice President of Research & Development

Philip Scumpia, MD, PhD

Philip Scumpia, MD, PhD

Vice President of Medical Affairs, Dermatology

Board of directors
Steven Sands

Steven Sands

Chairman

Eric Richman, MBA

Eric Richman, MBA

Director

Westbrook Weaver, PhD

Westbrook Weaver, PhD

Director

Donald Griffin, PhD

Donald Griffin, PhD

Director

Biren Mehta

Biren Mehta

Director

Erik Oros

Erik Oros

Director

Advisors
Dino Di Carlo, PhD

Dino Di Carlo, PhD

Founder, Scientific Advisor

Babak Azizzadeh, MD, FACS

Babak Azizzadeh, MD, FACS

Clinical Advisor

Tatiana Segura, PhD

Tatiana Segura, PhD

Founder, Scientific Advisor

Steve Yoelin, MD

Clinical Advisor

Bio coming soon
Community partners & collaborators

Built with partners in industry and academia.

Organizations Tempo has worked with across research, development and financing.

Funding
  • $14.5MSeptember 2026
  • $12MMarch 2024
Research support
  • ~$2.25MNIH / National Cancer Institute SBIR award, 2026
  • ~$5.5MAdditional NIH & NSF grant funding received since 2017
  • MedTech Innovator2025 Accelerator Cohort
Careers

Explore careers